Gene · 2122
Papers2,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic pan-cancer analysis of the prognostic value of MECOM in human cancer. | Discov Oncol | 2024 | 39576394 | PubTator, text mining | PubMed |
| MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentials. | Mol Med | 2024 | 39468462 | PubTator, text mining | PubMed |
| MECOM Locus classical transcript isoforms affect tumor immune microenvironment and different targets in ovarian cancer. | J Ovarian Res | 2024 | 39427186 | PubTator, text mining | PubMed |
| Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy. | N Engl J Med | 2024 | 39383458 | PubTator, text mining | PubMed |
| [The role and regulation of EVI1 in normal hematopoiesis and hematopoietic malignancies]. | Rinsho Ketsueki | 2024 | 39358295 | PubTator, text mining | PubMed |
| Prognostic Protein Biomarker Screening for Thyroid Carcinoma Based on Cancer Proteomics Profiles. | Biomedicines | 2024 | 39335579 | PubTator, text mining | PubMed |
| The microprotein HDSP promotes gastric cancer progression through activating the MECOM-SPINK1-EGFR signaling axis. | Nat Commun | 2024 | 39333095 | PubTator, text mining | PubMed |
| Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes. | Leuk Res | 2024 | 39316992 | PubTator, text mining | PubMed |
| PRDM3/16 regulate chromatin accessibility required for NKX2-1 mediated alveolar epithelial differentiation and function. | Nat Commun | 2024 | 39284798 | PubTator, text mining | PubMed |
| Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis. | Nat Commun | 2024 | 39227582 | PubTator, text mining | PubMed |
| Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCs. | Br J Haematol | 2024 | 39187468 | PubTator, text mining | PubMed |
| [Advances in genetic research on Non-syndromic congenital joint synostosis]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39097287 | PubTator, text mining | PubMed |
| Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer's Disease Cohorts. | J Alzheimers Dis | 2024 | 39093073 | PubTator, text mining | PubMed |
| CRISPR-Cas9-mediated deletion enhancer of MECOM play a tumor suppressor role in ovarian cancer. | Funct Integr Genomics | 2024 | 38995475 | PubTator, text mining | PubMed |
| Potential molecular and cellular mechanisms of the effects of cuproptosis-related genes in the cardiomyocytes of patients with diabetic heart failure: a bioinformatics analysis. | Front Endocrinol (Lausanne) | 2024 | 38883603 | PubTator, text mining | PubMed |
| IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia. | Haematologica | 2024 | 38841778 | PubTator, text mining | PubMed |
| Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML. | Nat Commun | 2024 | 38834613 | PubTator, text mining | PubMed |
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group. | Br J Haematol | 2024 | 38811025 | PubTator, text mining | PubMed |
| Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2. | Sci Adv | 2024 | 38748792 | PubTator, text mining | PubMed |
| Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. | Int J Hematol | 2024 | 38748089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2122/papers?page=7